NCT Number: NCT05452265
The investigators conducted a retrospective study of those patients with gastric SETs receiving ER or LR at the operative theater in the single institution from January 2013 to December 2021. Medical records were retrospectively reviewed to define patient/tumor characteristics and operative outcomes.
Looking for future studies?
Notify Me18 year–99 year
All sexes
Observational
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Complete resection of gastric SETs was recommended if the tumor size was >2 cm, presence of malignant features, or if the patient was symptomatic, declined periodical surveillance, and preferred to undergo diagnostic and therapeutic resection.
Other names: Laparoscopic resection
Time frame: during the procedure/surgery
minutes of procedure time
Time frame: upto one month after surgery
days of hospitalization
Time frame: upto one month after surgery
complications required further intervention, clavien dindo classification upto Grade III
Changhua Christian Hospital
Other
Different Approach of Minimal Invasive Surgery for Gastric Subepithelial Tumor From A Single-Center Experience
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03037034
Gastric Subepithelial Tumor
Seoul, Anamdong , Seongbuk-gu, South Korea
View Trial Details